Do not stop or change your medication without speaking to a pharmacist or healthcare professional.
Anticipated Shortage

DANTROLENE SODIUM FOR INJECTION, USP

HIKMA CANADA LIMITED

This is a national manufacturer shortage report. It does not confirm whether the product is unavailable at your local pharmacy — call ahead or ask your pharmacist.

Quick answers

Is there a shortage of DANTROLENE SODIUM FOR INJECTION, USP in Canada?

A shortage of DANTROLENE SODIUM FOR INJECTION, USP 20MG is expected: the manufacturer reported it to Health Canada as an anticipated shortage (last updated August 27, 2026), but it has not started yet.

Why is DANTROLENE SODIUM FOR INJECTION, USP not available?

The reason the manufacturer reported: Demand increase for the drug.

When will DANTROLENE SODIUM FOR INJECTION, USP be available again?

The manufacturer's estimated resolution date is December 18, 2026. This is an estimate and can change; follow this page to get an email when the status changes.

Can I still get this?Possibly — same-ingredient product records found
StatusAnticipated Shortage
Same-ingredient products on file2 products
Expected resolution~3 months remaining (estimate)
Affected strength20MG
Last updated2026-08-27

Other Products Containing the Same Active Ingredient

These are other Health Canada-approved human drug products containing the same active ingredient, not currently reported in shortage. Strength, dosage form, and route can still differ — ask your pharmacist whether any of these are appropriate for you. This isn't a guarantee of current stock.

Other Products

DANTRIUM CAP 100MG

NORWICH EATON CANADA INC.

100MG · DIN 00452521

Different strengthDifferent dosage formDifferent routeNo current shortage

DANTRIUM CAP 25MG

NORWICH EATON CANADA INC.

25MG · DIN 00452513

Different strengthDifferent dosage formDifferent routeNo current shortage

What this means

Does this mean my pharmacy is already out of stock?

No — this shortage hasn't started yet. It's an early warning that supply may become tight, based on information from the manufacturer.

What should I do?

No action is needed yet. It's worth asking your pharmacist at your next refill whether they expect any disruption for this product.

DIN

02529998

Strength

20MG

Dosage Form

POWDER FOR SOLUTION

Route

INTRAVENOUS

Active Ingredient

DANTROLENE SODIUM

See all DANTROLENE SODIUM products →

Shortage Timeline

Approximate — based on the dates HPSC reports were last updated, not confirmed onset or resolution dates. Gaps between bars are periods with no shortage on file.

Active/anticipated Resolved

Shortage History